The global infection control market is projected to grow from USD 57.31 billion in 2025 to USD 77.67 billion by 2030, registering a CAGR of 6.3% during the forecast period. The market is experiencing sustained expansion as healthcare systems, pharmaceutical manufacturers, medical device companies, and food processing industries intensify their focus on preventing the spread of infectious diseases and ensuring patient safety.
The growing burden of healthcare-associated infections (HAIs), increasing surgical volumes, advances in sterilization technologies, and the rising adoption of outsourced infection control services are reshaping the competitive landscape. Infection prevention has evolved from a compliance-driven function into a core operational and strategic priority for healthcare organizations worldwide.
Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1084
Why Infection Control Has Become a Global Healthcare Imperative
Infection control encompasses the sterilization, disinfection, decontamination, and monitoring practices used to prevent the transmission of infectious agents in healthcare and life science environments. The market includes:
- Sterilization equipment
- Washer-disinfectors
- Automated endoscope reprocessors
- Disinfectants and antiseptics
- Hand hygiene products
- Surface decontamination systems
- Sterile processing consumables
- Contract sterilization services
- Environmental monitoring solutions
As healthcare delivery becomes more complex and invasive procedures increase globally, maintaining effective infection prevention programmes is essential for reducing complications, controlling costs, and improving clinical outcomes.
Key Drivers Fueling Market Growth
Rising prevalence of healthcare-associated infections
HAIs remain one of the most significant challenges facing healthcare systems worldwide. Infections acquired during hospitalization can lead to:
- Extended hospital stays
- Increased morbidity and mortality
- Higher treatment costs
- Greater antimicrobial resistance risks
- Financial penalties linked to quality performance metrics
This has intensified investment in advanced sterilization systems, high-level disinfection technologies, and automated reprocessing solutions that reduce human error and improve consistency.
Growth in surgical procedures
The increasing volume of orthopaedic, cardiovascular, gastrointestinal, oncology, and minimally invasive surgeries is driving demand for reliable instrument sterilization and surgical support products.
Modern surgical environments require rapid turnaround of complex reusable instruments, creating strong demand for:
- Steam sterilizers
- Low-temperature sterilization systems
- Instrument tracking technologies
- Sterilization containers
- Automated cleaning and disinfection systems
Advances in reprocessing technologies
Healthcare providers are adopting automated and digitally integrated reprocessing solutions that enhance:
- Sterilization cycle validation
- Process traceability
- Equipment utilization efficiency
- Compliance with regulatory standards
- Infection risk reduction
Particularly important is the growing use of automated endoscope reprocessors, as endoscope-related infections have received significant regulatory and clinical attention in recent years.
Increased focus on food sterilization and public health
Beyond healthcare, infection control technologies are increasingly used in food processing and packaging applications to reduce microbial contamination and improve food safety. This diversification is expanding the addressable market for sterilization and disinfection providers.
Outsourcing of sterilization and infection control services
Pharmaceutical companies, medical device manufacturers, and hospitals are increasingly outsourcing specialized sterilization and decontamination functions to dedicated service providers. Outsourcing offers:
- Access to specialized expertise
- Reduced capital expenditure
- Regulatory compliance support
- Scalability for fluctuating demand
- Faster processing turnaround
This trend is creating significant growth opportunities for contract sterilization service providers.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1084
Industry Developments Reshaping the Market
Solventum becomes an independent healthcare company
In April 2024, Solventum completed its spinoff from 3M and began trading independently on the New York Stock Exchange under the ticker symbol “SOLV.”
As an independent healthcare-focused company, Solventum is positioned to:
- Accelerate innovation in infection prevention
- Expand its healthcare technology portfolio
- Improve operational agility
- Pursue targeted acquisitions and partnerships
- Focus resources specifically on healthcare growth opportunities
The separation allows Solventum to sharpen its strategic focus on patient outcomes, healthcare efficiency, and infection prevention solutions.
STERIS expands its healthcare portfolio
In August 2023, STERIS acquired the surgical instrumentation, laparoscopic instrumentation, and sterilization container assets from Becton, Dickinson and Company.
This acquisition strengthens STERIS by:
- Expanding its surgical support portfolio
- Enhancing its sterilization container offerings
- Increasing cross-selling opportunities within hospitals
- Deepening its presence in sterile processing departments
- Complementing its existing infection prevention ecosystem
The transaction reflects the industry’s broader trend toward integrated infection control and surgical workflow solutions.
Competitive Landscape
The infection control market is characterized by a combination of global healthcare technology leaders, hygiene specialists, sterilization service providers, and diversified medical technology companies.
Major participants include:
- STERIS (US)
- Reckitt Benckiser Group plc. (UK)
- Fortive (US)
- Sotera Health (US)
- Solventum (US)
These companies are pursuing both organic strategies (product launches, approvals, R&D investment) and inorganic strategies (acquisitions, partnerships, geographic expansion) to strengthen their market positions.
Company Spotlight: STERIS
STERIS is widely regarded as a global leader in infection prevention and contamination control. The company’s portfolio spans virtually every major segment of the infection control value chain.
Core offerings
STERIS provides:
- Steam sterilizers
- Low-temperature sterilization systems
- Washer-disinfectors
- Automated endoscope reprocessors
- Cleaning and disinfecting chemistries
- Surgical support products
- Sterile processing consumables
- Contract sterilization services
Competitive strengths
The company’s leadership is supported by:
- A broad and integrated product portfolio
- Strong relationships with hospitals and life science customers
- Extensive global service infrastructure
- Continuous investment in automation and digital technologies
- Strategic acquisitions that expand adjacent capabilities
STERIS has positioned itself as a comprehensive infection prevention partner for hospitals, pharmaceutical manufacturers, biotechnology companies, and research institutions seeking end-to-end sterilization and decontamination solutions.
Company Spotlight: Reckitt Benckiser Group plc.
Reckitt Benckiser is a major global player in hygiene and infection control, with internationally recognized brands such as Dettol and Lysol.
Product portfolio
The company offers:
- Disinfectants
- Antiseptics
- Hand hygiene products
- Surface cleaners
- Sanitizers
- Germ-protection solutions for consumer and professional markets
Strategic positioning
Reckitt has strengthened its infection control presence through:
- Continued investment in core hygiene and health brands
- Innovation in germ-protection formulations
- Expansion of business-to-business (B2B) distribution channels
- Increased institutional and healthcare-focused product offerings
During major public health emergencies, including the COVID-19 pandemic, Reckitt demonstrated its ability to rapidly scale production and distribution of disinfectant products, reinforcing its global brand strength and operational resilience.
Market Ranking: The Leading Five Players
The market is dominated by five major companies:
- STERIS
- Reckitt Benckiser Group plc.
- Fortive
- Sotera Health
- Solventum
These companies differentiate themselves through strong R&D capabilities, broad product portfolios, global distribution networks, and specialized infection prevention expertise.
STERIS: Integration and partnerships
STERIS has strengthened its leadership through strategic acquisitions and partnerships that expand its sterile processing and surgical support capabilities.
Reckitt: Global reach and brand power
Reckitt benefits from worldwide consumer and institutional distribution networks, giving it exceptional market penetration across both healthcare and non-healthcare hygiene applications.
Sotera Health: Facility footprint expansion
Sotera Health has expanded its presence by increasing its sterilization facility footprint in the United States, enhancing capacity for medical device and pharmaceutical sterilization services.
Strategic Moves Transforming the Competitive Landscape
Fortive’s acquisition of ASP
Fortive significantly strengthened its infection control position through the acquisition of Advanced Sterilization Products (ASP), a recognized leader in sterilization and high-level disinfection technologies.
The acquisition provides Fortive with:
- A stronger hospital reprocessing portfolio
- Access to ASP’s established global customer base
- Expanded low-temperature sterilization capabilities
- Greater exposure to recurring consumables and service revenue
- Enhanced international market reach
This move has elevated Fortive’s position in the hospital sterilization and instrument reprocessing segment.
Solventum’s independent growth strategy
As an independent company, Solventum can now:
- Prioritize infection prevention innovation
- Allocate capital specifically to healthcare opportunities
- Pursue targeted acquisitions without broader conglomerate constraints
- Accelerate product development cycles
- Build a distinct healthcare-focused brand identity
This strategic flexibility is expected to enhance Solventum’s competitiveness in the evolving infection control market.
Emerging Trends Shaping the Future
Automation and digital sterilization management
Hospitals are increasingly adopting digitally connected sterile processing departments that provide:
- Real-time cycle monitoring
- Instrument traceability
- Predictive maintenance alerts
- Compliance documentation
- Workflow optimization analytics
These capabilities improve both operational efficiency and regulatory compliance.
Low-temperature sterilization growth
The increasing use of heat-sensitive medical devices, including flexible endoscopes and advanced minimally invasive surgical instruments, is driving demand for low-temperature sterilization technologies such as hydrogen peroxide vapor systems.
Sustainability in infection control
Healthcare organizations are seeking solutions that reduce:
- Water consumption
- Energy usage
- Chemical waste
- Packaging waste
- Environmental impact of sterilization processes
Manufacturers are responding with more energy-efficient sterilizers, concentrated disinfectant formulations, and recyclable consumables.
Integrated infection prevention ecosystems
Future competitive advantage will increasingly come from offering integrated solutions that combine equipment, consumables, software, analytics, and service support rather than standalone products.
Regional Outlook
North America
North America remains the largest infection control market, supported by:
- Advanced healthcare infrastructure
- Stringent regulatory standards
- High surgical procedure volumes
- Strong adoption of automated reprocessing technologies
- Significant investment in hospital-acquired infection reduction programmes
Europe
European growth is driven by:
- Strict infection prevention regulations
- Aging healthcare infrastructure modernization
- Increased focus on antimicrobial resistance
- Expansion of outpatient and minimally invasive surgical services
Asia Pacific
Asia Pacific is expected to experience the fastest growth, fueled by:
- Rapid healthcare infrastructure expansion
- Rising healthcare expenditure
- Increasing surgical volumes
- Growing awareness of infection prevention
- Expansion of pharmaceutical and medical device manufacturing industries
Countries such as China, India, Japan, and South Korea represent particularly attractive long-term opportunities.
Strategic Opportunities for Stakeholders
For healthcare providers
Hospitals should prioritize:
- Automated sterile processing technologies
- Endoscope reprocessing modernization
- Digital traceability systems
- Staff training and competency management
- Integrated infection prevention analytics
For pharmaceutical and medical device manufacturers
Key opportunities include:
- Outsourced sterilization partnerships
- Advanced contamination control solutions
- Validation and monitoring technologies
- Sustainable sterilization processes
- Global compliance support services
For investors and technology vendors
High-growth areas include:
- Low-temperature sterilization systems
- Automated endoscope reprocessors
- Contract sterilization services
- Digital sterile processing software
- AI-enabled infection surveillance platforms
Future Outlook: Infection Control as a Strategic Infrastructure Investment
The infection control market is evolving beyond traditional cleaning and sterilization products toward technology-enabled infection prevention ecosystems. Future growth will be driven by the convergence of:
- Automation
- Digital monitoring
- Data analytics
- Regulatory compliance
- Sustainability initiatives
- Outsourced specialized services
Healthcare organizations increasingly view infection prevention as a strategic infrastructure investment that directly influences patient safety, operational performance, reimbursement outcomes, and institutional reputation.
Companies capable of delivering integrated, automated, and data-driven infection control solutions will be best positioned to capture market share as healthcare systems worldwide continue to strengthen their infection prevention capabilities.
Conclusion
The global infection control market is projected to reach USD 77.67 billion by 2030, growing at a 6.3% CAGR from 2025. Growth is being fueled by the rising burden of healthcare-associated infections, increasing surgical volumes, advances in sterilization and reprocessing technologies, expanding food safety requirements, and the growing outsourcing of specialized infection control services.
Industry leaders such as STERIS, Reckitt Benckiser, Fortive, Sotera Health, and Solventum are strengthening their positions through product innovation, strategic acquisitions, geographic expansion, and enhanced service capabilities. Notably, STERIS’s acquisition of BD sterilization assets, Fortive’s acquisition of ASP, and Solventum’s emergence as an independent healthcare company are reshaping the competitive dynamics of the market.
As healthcare systems continue to prioritize patient safety, regulatory compliance, operational efficiency, and antimicrobial resistance prevention, infection control will remain one of the most critical and strategically important segments of the global healthcare industry, creating substantial opportunities for technology providers, service organizations, and healthcare institutions through 2030 and beyond.
Get Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1084